Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Judy Lam-Tran to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033
Powered by
SC CTSI